Kalderos is a healthcare technology company focused on improving transparency and compliance across U.S. drug discount programs. Now part of Model N, it brings providers, drug manufacturers, and state payers together through a cloud-based Drug Discount Management platform. The platform uses data, artificial intelligence, and machine learning to identify potential noncompliance, support verification, and help stakeholders resolve disputes.

Kalderos offers solutions for Medicaid Drug Rebate Program (MDRP) discount monitoring, commercial discount monitoring, and Truzo, which helps prevent noncompliant discounts. Its products also include Discount Hub, which organizes 340B good faith inquiries, and state dispute reports that support collaboration between states and manufacturers. For covered entities, the platform helps manage inquiries and strengthen compliance checks; manufacturers can use it to identify high-risk claims and reduce revenue leakage; state payers can review data, identify potential duplicate discounts, and address data integrity issues.

By streamlining communication and dispute workflows, Kalderos aims to help drug discount programs work as intended and support the sustainability of healthcare services for patients and communities.